Vascular Perfusion Solutions, Inc. Announces Appointment of Interim Board Chair SAN ANTONIO, TEXAS, Aug. 01, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Vascular Perfusion Solutions, Inc. is pleased to announce the appointment of Dr. Thomas C. Mayes as the Interim...

Vascular Perfusion Solutions and Unravel Biosciences announce partnership to modulate endothelial activation during heart preservation to improve heart transplant outcomes BOSTON, Mass., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Vascular Perfusion Solutions (VPS) and Unravel Biosciences, Inc. (“Unravel”) are partnering to develop a proprietary perfusion solution that will...

Vascular Perfusion Solutions Collaborates with Wyss Institute and U.S. Air Force to Study Compound to Improve Organ Transplant Outcomes SAN ANTONIO, April 13, 2022 (GLOBE NEWSWIRE) -- To enhance its research on extending the viability of organs outside the body for the purpose of organ transplant, Vascular Perfusion Solutions (VPS)...